Pathology and Imaging of Cervical Cancer

Exam Tip: When evaluating a suspected neuroendocrine tumor, remember the hierarchy of IHC: CD56/Synaptophysin for sensitivity, and Chromogranin for specificity.

Microinvasive Disease and LVSI

A critical distinction in pathology is the presence of Lymphovascular Space Invasion (LVSI). Microinvasive disease is defined as FIGO stage IA1 without LVSI, which carries a very low risk (<1%) of lymphatic metastasis. The presence of LVSI significantly alters the staging and the subsequent surgical approach.

Imaging Principles for Staging and Surveillance

Imaging is not a "one size fits all" process; the modality chosen depends on the suspected stage and the specific tumor type.

Local and Regional Assessment

• Pelvis MRI: This is the preferred modality for assessing the local extent of the disease. It is particularly vital for patients in FIGO stage IB1–IB3 and for those being evaluated for fertility-sparing treatments like trachelectomy.
• FDG-PET/CT: For patients with more advanced disease (stages IB1–IVA), FDG-PET/CT is the preferred method to evaluate for metastatic involvement in the neck, chest, abdomen, pelvis, and groin.

Specialized Imaging for NECC

Because of its aggressive nature, Small Cell NECC requires a more extensive diagnostic workup than other cervical cancers. Clinicians should utilize FDG-PET/CT combined with a brain MRI to thoroughly assess for distant metastases.

Clinical Management and FIGO Staging

Treatment is stratified based on the FIGO stage, with a heavy emphasis on balancing oncologic control with the patient's desire for future fertility.

Fertility-Sparing Strategies

For patients in early stages (IA2–IB1) who wish to preserve fertility, several options exist depending on the specific tumor characteristics:

• Cone Biopsy: For Stage IA1 (no LVSI), a cone biopsy with negative margins (at least 1 mm) is a primary conservative option.
• Radical Vaginal Trachelectomy: For selected individuals with lesions <2 cm, this procedure can be performed to preserve the uterus.
• Sentinel Lymph Node (SLN) Mapping: This is often used in conjunction with conservative surgeries (like conization or trachelectomy) to assess nodal status while minimizing surgical morbidity.

Non-Fertility Sparing Management

As the disease progresses, the focus shifts from preservation to radical eradication:

• Stage IA1 (with LVSI): May require a Type A hysterectomy plus SLN mapping or pelvic lymphadenectomy.
• Locally Advanced Disease (Stage IIB–IVA): Management typically involves a combination of pelvic External Beam Radiation Therapy (EBRT), brachytherapy, and concurrent platinum-containing chemotherapy.

Clinical Note: For Stage IA1 with positive margins that are medically inoperable, pelvic EBRT ± brachytherapy may be considered.

Summary of Management by Stage

The following table summarizes the general approach to management based on FIGO staging:

By integrating pathological markers like p16 and synaptophysin with targeted imaging protocols, clinicians can navigate the complexities of cervical cancer to provide highly individualized and effective care.